Industry Sentiment Dossier
Pharmaceutical Retailers sentiment intelligence
Company-news tone, narrative breadth, confidence, catalyst concentration and market confirmation examined as separate evidence layers.
Executive Evidence Brief
A balanced headline masks a selective company tape
Aggregate tone remains near neutral, so breadth, catalysts and company-level outliers carry more information than the headline score alone.
Evidence that supports the read
Direct company coverage supplies 100% of the measured article set.
Conditions that limit conviction
Evidence confidence is 64/100 and should limit conviction in the aggregate read.
Only 44% of measured equities have a positive one-week response.
Narrative Breadth
How widely tone is shared
Score Distribution
Shape of the company tape
Evidence Quality
Reliability of the read
431 relevant story observations across 247 publisher signals. 100% is direct company evidence.
13-Week Trajectory
Weighted tone and participation
The path uses a fixed quality sample of up to 43 current constituents to keep the historical query reproducible. Earlier observations are not rewritten by later headlines.
Market Confirmation
How price is responding to the news tape
Price response is a diagnostic cross-check. It does not alter the sentiment score, so agreement and disagreement remain visible.
Internal Leadership
Country map
13 thin groups are withheld because they contain fewer than 5 qualified securities.
Narrative Dispersion
Parent-sector context
Strongest tone
Healthcare52.643 equities · 64/100 confidenceWeakest tone
Healthcare52.643 equities · 64/100 confidencePeer Comparison
Where this read sits in the ranked tape
Catalyst Lens
What is moving the narrative
Publisher Lens
Where the latest observations came from
Positioning Lens
What deserves attention
Security Evidence
The equities behind the read
Constructive leaders
Positive news being faded · -7.0% 1W
Analyst action · 75/100 confidence · 16 direct storiesNews confirmed by price · +1.6% 1W
Earnings · 75/100 confidence · 11 direct storiesBalanced read · -1.4% 1W
Market update · 75/100 confidence · 58 direct storiesPrice moving ahead of tone · -13.7% 1W
Market update · 73/100 confidence · 19 direct storiesBalanced read · -1.8% 1W
Earnings · 56/100 confidence · 2 direct storiesBalanced read · -0.3% 1W
Market update · 45/100 confidence · 4 direct storiesBalanced read · -0.2% 1W
Earnings · 77/100 confidence · 13 direct storiesBalanced read · +1.3% 1W
Earnings · 66/100 confidence · 7 direct storiesCautious laggards
Balanced read · -0.6% 1W
Market update · 24/100 confidence · 2 direct storiesPrice moving ahead of tone · -22.5% 1W
Market update · 75/100 confidence · 42 direct storiesBalanced read · -1.5% 1W
Market update · 75/100 confidence · 15 direct storiesBalanced read · +3.9% 1W
Market update · 75/100 confidence · 16 direct storiesPrice moving ahead of tone · +33.3% 1W
Market update · 75/100 confidence · 15 direct storiesBalanced read · -3.5% 1W
Market update · 75/100 confidence · 11 direct storiesBalanced read · +0.2% 1W
Market update · 51/100 confidence · 3 direct storiesBalanced read · -3.3% 1W
Earnings · 46/100 confidence · 2 direct storiesAttention leaders
Balanced read · -1.4% 1W
Market update · 75/100 confidence · 58 direct storiesPrice moving ahead of tone · -22.5% 1W
Market update · 75/100 confidence · 42 direct storiesBalanced read · -2.2% 1W
Market update · 75/100 confidence · 31 direct storiesBalanced read · +0.3% 1W
Market update · 75/100 confidence · 26 direct storiesBalanced read · +1.5% 1W
Earnings · 86/100 confidence · 21 direct storiesPrice moving ahead of tone · -13.7% 1W
Market update · 73/100 confidence · 19 direct storiesPrice moving ahead of tone · -4.5% 1W
Market update · 75/100 confidence · 19 direct storiesPrice moving ahead of tone · +7.5% 1W
Market update · 75/100 confidence · 18 direct storiesLatest Evidence Ledger
Recent company-level observations
PetMed Express, Inc. expected to post earnings of 12 cents a share - Earnings Preview
TradingView · Earnings · Balanced read
86/100 confidence · 100% direct evidenceWill MatsukiyoCocokara's (TSE:3088) New Earnings Guidance Reset Expectations for Its Profitability Narrative?
simplywall.st · Earnings · Balanced read
56/100 confidence · 100% direct evidenceCOSMOS Pharmaceutical Revamps Board With New Corporate Planning Director
TipRanks · Market update · Balanced read
42/100 confidence · 100% direct evidenceAlibaba Health Information Technology Stock Climbs 2.1% in Hong Kong
Moomoo · Market update · Price moving ahead of tone
75/100 confidence · 100% direct evidenceDataMeds AI, Inc. (Nasdaq: MEDS) details 34,462,058-share resale
Stock Titan · Market update · Price moving ahead of tone
73/100 confidence · 100% direct evidenceScienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates
TradingKey · Earnings · Balanced read
77/100 confidence · 100% direct evidenceHigh Tide Inc. (HITI) Stock Price, News, Quote & History
Yahoo! Finance Canada · Market update · Balanced read
75/100 confidence · 100% direct evidenceCawachi Launches ¥2 Billion Share Buyback to Boost Shareholder Returns
TipRanks · Market update · Balanced read
45/100 confidence · 100% direct evidencePress Release: POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure
Moomoo · Market update · Price moving ahead of tone
75/100 confidence · 100% direct evidenceCVS Health (NYSE:CVS) Earnings Strength Sparks Fresh Market Focus
Kalkine Media · Market update · Balanced read
75/100 confidence · 100% direct evidenceShu Yu Civilian Pharmacy Corp., Ltd. Class A Revenue Breakdown – SZSE:301017
TradingView · Earnings · Price moving ahead of tone
24/100 confidence · 100% direct evidenceNahdi Medical Company (TADAWUL:4164) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
simplywall.st · Market update · Balanced read
51/100 confidence · 100% direct evidenceClicks lost R135 million in value every day in 2026 – but there’s a silver lining
businesstech.co.za · Market update · Balanced read
75/100 confidence · 100% direct evidenceFangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
BioSpace · Market update · Balanced read
60/100 confidence · 100% direct evidenceWhy TelyRx Holdings Inc. stock surged yesterday
Wealth Awesome · Market update · Balanced read
75/100 confidence · 100% direct evidenceIn HelloNation, Healthcare Services Expert Sheila A. Berschauer Explains What a Community Health Center Can Help With
PR Newswire · Market update · Balanced read
75/100 confidence · 100% direct evidenceEmpreendimentos Pague Menos SA Revenue Breakdown – BMFBOVESPA:PGMN3
TradingView · Market update · Price moving ahead of tone
36/100 confidence · 100% direct evidenceDaShenLin Pharmaceutical Group Co., Ltd. Class A Revenue Breakdown – SSE:603233
TradingView · Market update · Balanced read
33/100 confidence · 100% direct evidenceReproducible Method
How to read this dossier
The score measures the polarity of qualified published news after relevance, source quality, event importance and freshness weighting. It is centred at 50.
Breadth measures how widely constructive or cautious classifications are shared. A few extreme equities cannot create broad participation.
Confidence measures sample depth, direct-company coverage, publisher diversity, freshness and agreement. It is intentionally separate from direction.
Completed weekly price data tests whether the market confirms, rejects or absorbs the narrative. Price never feeds back into the sentiment score.
Unqualified ticker records are excluded, and subgroup maps require at least five qualified securities. Thin slices are disclosed instead of ranked.
This is a current evidence classification, not a forecast, target, recommendation or measure of investor positioning.